Pharmazz, Inc.
Clinical trials sponsored by Pharmazz, Inc., explained in plain language.
-
Could a shock drug help ARDS patients breathe easier? new trial launches
Disease control Not yet recruitingThis study tests whether centhaquine, a drug already approved for shock, can help people with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. About 80 ICU patients will receive centhaquine or a placebo alongside standard care. The…
Phase: PHASE2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New drug aims to save lives from shock due to blood loss
Disease control Not yet recruitingThis study tests a new medicine called centhaquine for people in hypovolemic shock, a life-threatening condition where the body doesn't have enough blood flow. About 430 adults will receive either centhaquine or a placebo alongside standard care. The main goal is to see if the dr…
Phase: PHASE3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC